StonvexLoading…
StonvexStonvexStonvexCore line items from RGLD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.03B | $719.39M | $605.72M | $603.21M |
Operating Income | $638.17M | $429.90M | $303.20M | $283.71M |
Net Income | $466.28M | $332.02M | $239.44M | $238.98M |
EPS (Diluted) | $6.69 | $5.04 | $3.63 | $3.63 |
Total Assets | $9.54B | $3.39B | $3.36B | $3.53B |
Total Liabilities | $2.33B | $260.92M | $460.42M | $781.05M |
Cash & Equivalents | $233.72M | $195.50M | $104.17M | $118.59M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 84.50M | 65.69M | 65.63M | 65.59M |